WebCTXR Citius Pharmaceuticals Inc 21,868 Watch Alerts Buy $1.37 $0.06 (4.58%) Today $1.37 0.00 (0.00%) Pre-Market Market Cap $200.37M Volume (M) 22.00 52-Wk High $1.61 52-Wk Low $0.77 About Feed Sentiment Fundamentals News There is no chart data available for this period 1d 1w 1m 3m 6m 1y All Sentiment Message Volume WebWhen does CTXR make money? Latest excerpt from Simply Wall St. Thoughts? According to some industry analysts covering Citius Pharmaceuticals, breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$56m in 2025. The company is therefore projected to breakeven around 2 years from …
CTXR Stock Analysis: Price, Forecast, and News
WebCitius Pharmaceuticals, Inc. (CTXR) Company Bio Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily … WebApr 5, 2024 · Their CTXR share price forecasts range from $6.00 to $6.00. On average, they predict the company's share price to reach $6.00 in the next twelve months. This … small business marketing costs
CTXR.O - Stock Price & Latest News Reuters
WebThe Mino-Lok Phase 3 Trial is planned to enroll 700 patients in 50 participating institutions, all located in the U.S. There will be interim analyses at the 50% and 75% point of the trial as measured by the number of patients treated. Citius reports that as of this past week there are 12 active sites currently enrolling patients including such ... WebApr 13, 2024 · Data on historical trading for Citius Pharmaceuticals Inc. (NASDAQ:CTXR) indicates that the trading volumes over the past 10 days have averaged 0.99 million and over the past 3 months, they’ve averaged 905.71K. According to company’s latest data on outstanding shares, there are 146.21 million shares outstanding. WebNews Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, … small business marketing facts